143 related articles for article (PubMed ID: 9120417)
1. Pathogenesis of immune-mediated demyelination in the CNS.
Hartung HP; Rieckmann P
J Neural Transm Suppl; 1997; 50():173-81. PubMed ID: 9120417
[TBL] [Abstract][Full Text] [Related]
2. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
Kerlero de Rosbo N; Mendel I; Ben-Nun A
Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
[TBL] [Abstract][Full Text] [Related]
3. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Weissert R; de Graaf KL; Storch MK; Barth S; Linington C; Lassmann H; Olsson T
J Immunol; 2001 Jun; 166(12):7588-99. PubMed ID: 11390515
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases.
Miller SD; McRae BL; Vanderlugt CL; Nikcevich KM; Pope JG; Pope L; Karpus WJ
Immunol Rev; 1995 Apr; 144():225-44. PubMed ID: 7590815
[TBL] [Abstract][Full Text] [Related]
5. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
Lee DH; Linker RA
Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of immunopathology in murine models of central nervous system demyelinating disease.
Ercolini AM; Miller SD
J Immunol; 2006 Mar; 176(6):3293-8. PubMed ID: 16517694
[TBL] [Abstract][Full Text] [Related]
7. [Epitopes on myelin proteins recognized by autoantibodies present in multiple sclerosis patients].
Jaśkiewicz E
Postepy Hig Med Dosw (Online); 2004; 58():472-82. PubMed ID: 15765008
[TBL] [Abstract][Full Text] [Related]
8. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice.
Mokhtarian F; Zhang Z; Shi Y; Gonzales E; Sobel RA
J Neuroimmunol; 1999 Mar; 95(1-2):43-54. PubMed ID: 10229114
[TBL] [Abstract][Full Text] [Related]
9. Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody.
Linington C; Engelhardt B; Kapocs G; Lassman H
J Neuroimmunol; 1992 Oct; 40(2-3):219-24. PubMed ID: 1385471
[TBL] [Abstract][Full Text] [Related]
10. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins.
Miller SD; Clatch RJ; Pevear DC; Trotter JL; Lipton HL
J Immunol; 1987 Jun; 138(11):3776-84. PubMed ID: 2438327
[TBL] [Abstract][Full Text] [Related]
11. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis.
Yu M; Johnson JM; Tuohy VK
J Neurosci Res; 1996 Aug; 45(4):463-70. PubMed ID: 8872907
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
[TBL] [Abstract][Full Text] [Related]
13. Autoimmunity in the central nervous system: mechanisms of antigen presentation and recognition.
Wucherpfennig KW
Clin Immunol Immunopathol; 1994 Sep; 72(3):293-306. PubMed ID: 8062444
[TBL] [Abstract][Full Text] [Related]
14. Myelin protein expression in lymphoid tissues: implications for peripheral tolerance.
Voskuhl RR
Immunol Rev; 1998 Aug; 164():81-92. PubMed ID: 9795766
[TBL] [Abstract][Full Text] [Related]
15. Immunologic mechanisms in chronic demyelinating diseases of the central and peripheral nervous system.
Wucherpfennig KW; Weiner HL
Res Publ Assoc Res Nerv Ment Dis; 1990; 68():105-16. PubMed ID: 2158131
[TBL] [Abstract][Full Text] [Related]
16. MOG-induced experimental autoimmune encephalomyelitis in the rat species triggers anti-neurofascin antibody response that is genetically regulated.
Flytzani S; Guerreiro-Cacais AO; N'diaye M; Lindner M; Linington C; Meinl E; Stridh P; Jagodic M; Olsson T
J Neuroinflammation; 2015 Oct; 12():194. PubMed ID: 26511327
[TBL] [Abstract][Full Text] [Related]
17. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis and their application for new therapeutic strategies.
Martin R
J Neural Transm Suppl; 1997; 49():53-67. PubMed ID: 9266414
[TBL] [Abstract][Full Text] [Related]
18. Encephalitogenic and neuritogenic T cell responses to the myelin-associated glycoprotein (MAG) in the Lewis rat.
Weerth S; Berger T; Lassmann H; Linington C
J Neuroimmunol; 1999 Mar; 95(1-2):157-64. PubMed ID: 10229126
[TBL] [Abstract][Full Text] [Related]
19. The functional significance of epitope spreading and its regulation by co-stimulatory molecules.
Vanderlugt CL; Begolka WS; Neville KL; Katz-Levy Y; Howard LM; Eagar TN; Bluestone JA; Miller SD
Immunol Rev; 1998 Aug; 164():63-72. PubMed ID: 9795764
[TBL] [Abstract][Full Text] [Related]
20. Insights into the aetiology and pathogenesis of multiple sclerosis.
Ewing C; Bernard CC
Immunol Cell Biol; 1998 Feb; 76(1):47-54. PubMed ID: 9553776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
